FIELD: medicine, peptides, pharmacy.
SUBSTANCE: invention relates to medicinal agents used in prophylaxis and correction of age disorders in cellular and humoral immunity. Invention proposes a pharmaceutical composition possessing immunogeroprotective effect and containing the effective amount of peptide glutamyl-aspartyl-proline of the general formula: H-Glu-Asp-Pro-OH of the sequence 1 [SEQ ID NO:1] as an active component. Invention proposes peptide glutamyl-aspartyl-proline of the general formula: H-Glu-Asp-Pro-OH of the sequence 1 [SEQ ID NO:1] that possesses immunogeroprotective effect. Also, invention proposes a method for prophylaxis and correction of age disorders in cellular and humoral immunity by stimulation of processes of proliferation and differentiation of lymphocytes. Method involves administration in a patient a pharmaceutical composition containing peptide glutamyl-aspartyl-proline of the formula: H-Glu-Asp-Pro-OH of the sequence 1 [SEQ ID NO:1] in the dose 0.01-100 mcg/kg of body mass as an active component at least once per a day for period necessary for providing the therapeutic effect. Invention provides creature of peptide possessing immunogeroprotective effect and pharmaceutical composition containing this peptide as an active component that stimulates processes of proliferation and differentiation of lymphocytes based on recovery in synthesis of tissue-specific proteins, normalization of metabolic and molecular-genetic indices in age disorders of cellular and humoral immunity. Proposed peptide can be used as an agent possessing immunogeroprotective effect.
EFFECT: valuable medicinal and biological properties of peptide.
6 cl, 4 tbl, 2 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
TETRAPEPTIDE REGULATING PROSTATE FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2001 |
|
RU2177802C1 |
PEPTIDE STIMULATING REGENERATION OF LIVER TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2297239C1 |
METHOD OF PREPARING PEPTIDES SHOWING TISSUE-SPECIFIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2161501C1 |
PEPTIDE PHARMACEUTICAL COMPOSITION NORMALISING URINATION, AND METHOD OF APPLICATION THEREOF | 2007 |
|
RU2367467C2 |
PEPTIDE STIMULATING REGENERATION OF CENTRAL NERVOUS SYSTEM NEURONS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301678C1 |
PEPTIDE NORMALIZING METABOLISM IN OSSEOUS AND CARTILAGE TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2299741C1 |
PHARMACEUTICAL COMPOSITION ON BASIS OF PEPTIDE POSSESSING ANTITUMORAL ACTION | 2007 |
|
RU2362579C1 |
PEPTIDE POSSESSING STRESS-PROTECTING EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2304444C1 |
PEPTIDE ENHANCING RESISTANCE OF CAPILLARIES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2295970C1 |
PEPTIDE HAVING BRONCHOPROTECTIVE ACTION, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHOD FOR USE THEREOF | 2021 |
|
RU2767532C1 |
Authors
Dates
2007-06-20—Published
2006-05-30—Filed